Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lifco AB on acquisition of Oriola Oy’s minority holding in Lifco Dental International AB
Mandate

Vinge advises Lifco AB on acquisition of Oriola Oy’s minority holding in Lifco Dental International AB

November 11, 2010

Vinge is advising Lifco AB in connection with the acquisition of Oriola Oy’s 30 per cent minority holding in Lifco Dental International AB. Lifco Dental International AB is the leading Nordic supplier of dental products and after the acquisition, the company is a wholly owned subsidiary of Lifco AB.

Partner Erik Gabrielson is advising Lifco AB in connection with the acquisition.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026